MIAMI

Norwegian Cruise Line Holdings Unveils Bold New Vision for the Future with Strategic Long Term Fleet Expansion and Enhanced Private Island Development

Retrieved on: 
Monday, April 8, 2024
Growth, NCL, Regent Seven Seas Cruises, Exploration, Partnership, Norwegian Cruise Line, Norwegian Cruise Line Holdings, Cruise line, NCLH, Ship, Tourism

This unprecedented decade-long strategy enhances its product offering, guest experiences, and operational infrastructure, supporting the Company’s sustained leadership in delivering innovative cruise vacations.

Key Points: 
  • This unprecedented decade-long strategy enhances its product offering, guest experiences, and operational infrastructure, supporting the Company’s sustained leadership in delivering innovative cruise vacations.
  • The new ship orders across all three brands are scheduled for delivery over a ten-year period, between 2026 and 2036.
  • Details regarding the ships’ amenities, staterooms, dining, recreational, efficiency, sustainability and other features will be announced in the coming months.
  • A replay of the conference call will also be available on the website for 30 days after the call.

Smart for Life Releases Corporate Video on Definitive Agreement to Acquire Purely Optimal Nutrition

Retrieved on: 
Monday, April 8, 2024
Wellness, E-commerce, Cookie, Health, Adjustment, Acquisition, Mathematical optimization

MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today released a corporate video regarding the definitive agreement to acquire Purely Optimal Nutrition , a premier eCommerce nutraceuticals company with operations in North America.

Key Points: 
  • MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today released a corporate video regarding the definitive agreement to acquire Purely Optimal Nutrition , a premier eCommerce nutraceuticals company with operations in North America.
  • The corporate video featuring Smart for Life’s CEO, Darren Minton, can be found at: https://smartforlifecorp.com/2024/04/08/video-ceo-of-smart-for-life-darr... .
  • “We are excited to announce another milestone as part of our M&A strategy, designed to establish Smart for Life as a major international force in the Health & Wellness sector,” stated Darren Minton, CEO of Smart for Life.
  • Purely Optimal is currently generating estimated revenue in excess of $8 million and over $1 million of Adjusted EBITDA for the trailing twelve months.

Smart for Life Announces Definitive Agreement to Acquire Purely Optimal Nutrition, a Premier North American Nutraceutical Company

Retrieved on: 
Monday, April 8, 2024
E-commerce, Health, Life, Acquisition, Cookie, Adjustment, Wellness, FDA, Mathematical optimization

MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that it has executed a definitive agreement to acquire Purely Optimal Nutrition , a premier eCommerce nutraceuticals company with operations in North America.

Key Points: 
  • MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that it has executed a definitive agreement to acquire Purely Optimal Nutrition , a premier eCommerce nutraceuticals company with operations in North America.
  • Cervantes, Jr., Smart for Life’s founder and Chairman, stated, “We are very excited to have Purely Optimal join forces under the Smart for Life umbrella.
  • Purely Optimal’s product line is designed to yield optimal results with carefully sourced and nourishing ingredients from all around the world.
  • Purely Optimal is currently generating estimated revenue in excess of $8 million and over $1 million of Adjusted EBITDA for the trailing twelve months.

Captivision Showcases Entertainment Partners for Framework in the Desert Event

Retrieved on: 
Monday, April 8, 2024
Partnership, United, Glass, Aviation, Macquarie Infrastructure Corporation, Entertainment

Captivision will deliver a unique media glass installation over three nights from Friday, April 12 through Sunday, April 14.

Key Points: 
  • Captivision will deliver a unique media glass installation over three nights from Friday, April 12 through Sunday, April 14.
  • This collaboration marks the inception of a new area of strategic focus for Captivision dedicated to pushing boundaries and redefining the live entertainment experience.
  • The Captivision installation will play digital content from the entertainment partners and Framework including art, trailers, and advertisements throughout the Framework in the Desert event at the Atlantic Aviation airport hangar in Thermal, California.
  • “We are excited to join forces with Framework and our entertainment partners to energize the Framework in the Desert audience,” said Gary Garrabrant, Captivision Chairman & CEO.

Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals

Retrieved on: 
Monday, April 8, 2024
SOC, CDMO, Orphan drug, Letter, Cell, Science, Bone marrow, Disease, Partnership, Caregiver, Hypoplastic left heart syndrome, Patient, Fast Track, Research, Microsoft Exchange Server, Standard of care, Security (finance), CLEAR, Surgeon, Regenerative medicine, FDA, BLA, Development, Pharmaceutical industry

MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that the Company’s CEO, Wa’el Hashad, issued the following letter to Longeveron shareholders.

Key Points: 
  • MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that the Company’s CEO, Wa’el Hashad, issued the following letter to Longeveron shareholders.
  • Today, I am excited to update you on our overall strategy, business objectives, approach to capital allocation, and 2024 key priorities and goals.
  • Our focus remains steadfast on raising the funds necessary to continue our operations and delivering transformative solutions to patients and creating sustainable value for our shareholders.
  • In 2024, we are focusing our efforts on two of our most promising programs: Hypoplastic Left Heart Syndrome (HLHS); and Alzheimer’s Disease.

Ibogaine By David Dardashti Investigates Impact of Quantum Physics on April 8 Solar Eclipse

Retrieved on: 
Friday, April 5, 2024
Solar System, Moon

MIAMI, April 04, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti has uncovered a unique opportunity for those seeking to experience the optimal potential of ibogaine treatment.

Key Points: 
  • MIAMI, April 04, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti has uncovered a unique opportunity for those seeking to experience the optimal potential of ibogaine treatment.
  • The ibogaine team has researched and investigated the direct impact of quantum electrodynamics and electromagnetic waves on the body's response to the ibogaine treatment.
  • If you're looking to maximise the potential of your ibogaine treatment session, Ibogaine By David Dardashti invites you to take advantage of this rare opportunity.
  • We believe that the April 8th solar eclipse presents an unprecedented chance to experience the optimal potential of ibogaine.

Safe & Green Holdings Corp to Report Financial Results and File Its Form 10-K for the Year Ended December 31, 2023, on April 15, 2024

Retrieved on: 
Thursday, April 4, 2024
Form 10-K

Miami, FL, April 04, 2024 (GLOBE NEWSWIRE) -- Safe & Green Holdings Corp. (NASDAQ: SGBX Safe & Green Holdings” or the “Company”), a leading developer, designer, and fabricator of modular structures for residential, commercial, and point-of-care medicine, today announced that the Company has filed an extension and plans to report its financial results and file its Form 10-K for the year ended December 31, 2023, on April 15, 2024.

Key Points: 
  • Miami, FL, April 04, 2024 (GLOBE NEWSWIRE) -- Safe & Green Holdings Corp. (NASDAQ: SGBX Safe & Green Holdings” or the “Company”), a leading developer, designer, and fabricator of modular structures for residential, commercial, and point-of-care medicine, today announced that the Company has filed an extension and plans to report its financial results and file its Form 10-K for the year ended December 31, 2023, on April 15, 2024.
  • Paul Galvin, Chairperson and CEO of Safe and Green commented, “We are looking forward to providing our shareholders with a review of our results as well as a business update.”

Study Investigators Conclude RapidPulse™ Precise Cyclic Aspiration Is Highly Effective and Safe for Ischemic Stroke Large Vessel Occlusions

Retrieved on: 
Thursday, April 4, 2024
Brain, Ambient occlusion, AIS, Cerebral infarction, Patient, Stroke, Sale, Thrombolysis, Reperfusion, FDA, Interventional Neuroradiology, Medical device

RapidPulse is a spin-out of Syntheon 2.0, LLC, an innovative medical device incubator with a long track record of successful exits.

Key Points: 
  • RapidPulse is a spin-out of Syntheon 2.0, LLC, an innovative medical device incubator with a long track record of successful exits.
  • In this study, 40 patients were enrolled in the RapidPulse arm and treated using an 0.071-inch catheter.
  • The investigators used commercially available aspiration catheters ranging in size from 0.070 to 0.072 to treat the control arm patients with standard aspiration pumps.
  • Dr. Serdar Geyik from Istanbul's Aydin University commented, “This is an exciting improvement for the treatment of ischemic stroke due to large vessel occlusion.

Safe and Green Development Corp Announces XENE Home AI Beta Launch

Retrieved on: 
Thursday, April 4, 2024
Rita of Armenia, SGD, Real estate, Innovation, SVP, Research, Lawyer, Property management

MIAMI, Fla, April 04, 2024 (GLOBE NEWSWIRE) -- Safe and Green Development Corporation (NASDAQ: SGD) (“SG DevCo” or the “Company”), is pleased to announce the Beta launch of the Xene AI Platform for the Real Estate industry.

Key Points: 
  • MIAMI, Fla, April 04, 2024 (GLOBE NEWSWIRE) -- Safe and Green Development Corporation (NASDAQ: SGD) (“SG DevCo” or the “Company”), is pleased to announce the Beta launch of the Xene AI Platform for the Real Estate industry.
  • This phase will allow our stakeholders to enjoy access to the platform and discover some of the initial AI features of the platform.
  • The Company plans to introduce advancements in AI real estate technology following the launch.
  • We are excited for this phase and even more excited for our forthcoming launch to the public very soon!”

Global Crossing Airlines, America’s Fastest Growing Charter Airline, Receives Increased Authorization for up to 20 Aircraft by US DOT

Retrieved on: 
Wednesday, April 3, 2024
Transport, Airbus, Nation, JET, A321, ACMI, Airbus A320 family, Aircraft, OTCQB, Airline

MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- Global Crossing Airlines Group, Inc. (Cboe: JET, OTCQB: JETMF) (the “Company” or “GlobalX”), the Nation's fastest growing charter airline, has been approved by the US Department of Transportation for an increase to 20 aircraft from its current authorization of 16 aircraft.

Key Points: 
  • MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- Global Crossing Airlines Group, Inc. (Cboe: JET, OTCQB: JETMF) (the “Company” or “GlobalX”), the Nation's fastest growing charter airline, has been approved by the US Department of Transportation for an increase to 20 aircraft from its current authorization of 16 aircraft.
  • The increased fleet authorization allows GlobalX to add two (2) Airbus A320 and two (2) Airbus A321 passenger aircraft to its fleet by Summer 2024, subject to FAA approvals.
  • The additional aircraft will strengthen GlobalX's refocused strategy to expand its ACMI passenger charter business.
  • “This increased authorization is a key step in our path to sustained profitability and achieving our goal to become America’s largest charter airline, setting the industry high mark for on-time performance and reliability,” said Chris Jamroz, Executive Chairman of GlobalX.